Development of a Prognostic Model for Early Breast Cancer Integrating Neutrophil to Lymphocyte Ratio and Clinical-Pathological Characteristics
The Oncologist · 04.04.2024 · 29 (4) · e447-e454
DOI: 10.1093/oncolo/oyad303 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Oncologist, online erschienen am 16.11.2023. Verfasst von Sara Socorro Faria und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immunology and Inflammation, Department of Cell Biology, University of Brasilia, DF Brasilia, Brazil. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Breast cancer-related inflammation is critical in tumorigenesis, cancer progression, and patient prognosis. Several inflammatory markers derived from peripheral blood cells count, such as the neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), monocyte-lymphocyte ratio (MLR), and systemic immune-inflammation index (SII) are considered as prognostic markers in several types of malignancy.
Methods
We investigate and validate a prognostic model in early patients with breast cancer to predict disease-free survival (DFS) based on readily available baseline clinicopathological prognostic factors and preoperative peripheral blood-derived indexes.
Results
We analyzed a training cohort of 710 patients and 2 external validation cohorts of 980 and 157 patients with breast cancer, respectively, with different demographic origins. An elevated preoperative NLR is a better DFS predictor than others scores. The prognostic model generated in this study was able to classify patients into 3 groups with different risks of relapse based on ECOG-PS, presence of comorbidities, T and N stage, PgR status, and NLR.
Conclusion
Prognostic models derived from the combination of clinicopathological features and peripheral blood indices, such as NLR, represent attractive markers mainly because they are easily detectable and applicable in daily clinical practice. More comprehensive prospective studies are needed to unveil their actual effectiveness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Immunology and Inflammation, Department of Cell Biology, University of Brasilia, DF Brasilia, Brazil.
- Department of Epidemiology and Biostatistics, GSTeP, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
- Department of Medical Oncology, A.C. Camargo Cancer Center, Sao Paulo, SPBrazil.
- Department of Surgery, Faculty of Medicine, Public Health and Nursing, Dr. Sardjito Hospital, Universitas Gadjah Mada, Yogyakarta, Indonesia.
- Department of Medical Oncology, IRCCS Instituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori," Meldola, Italy.
- Department of Melanoma, Cancer Immunotherapy and Development Therapeutics. Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale" Napoli, Italy.
ORCID-Profile: Diana Giannarelli, Gabriele Madonna, Paolo Antonio Ascierto, Rossana Veronica Mendoza López, Roger Chammas, Mariaelena Capone
Zitieren
APA
Faria, S. S., Giannarelli, D., Cordeiro de Lima, V. C., Anwar, S. L., Casadei, C., De Giorgi, U., Madonna, G., Ascierto, P. A., Mendoza López, R. V., Chammas, R., & Capone, M. (2024). Development of a Prognostic Model for Early Breast Cancer Integrating Neutrophil to Lymphocyte Ratio and Clinical-Pathological Characteristics. The Oncologist, 29(4), e447-e454. https://doi.org/10.1093/oncolo/oyad303
Vancouver
Faria SS, Giannarelli D, Cordeiro de Lima VC, Anwar SL, Casadei C, De Giorgi U, et al. Development of a Prognostic Model for Early Breast Cancer Integrating Neutrophil to Lymphocyte Ratio and Clinical-Pathological Characteristics. The Oncologist. 2024;29(4):e447-e454. doi:10.1093/oncolo/oyad303
BibTeX
@article{Faria2024,
author = {Faria, Sara Socorro and Giannarelli, Diana and Cordeiro de Lima, Vladmir Claudio and Anwar, Sumadi Luckman and Casadei, Chiara and De Giorgi, Ugo and Madonna, Gabriele and Ascierto, Paolo Antonio and Mendoza López, Rossana Veronica and Chammas, Roger and Capone, Mariaelena},
title = {Development of a Prognostic Model for Early Breast Cancer Integrating Neutrophil to Lymphocyte Ratio and Clinical-Pathological Characteristics},
journal = {The Oncologist},
year = {2024},
volume = {29},
number = {4},
pages = {e447--e454},
doi = {10.1093/oncolo/oyad303}
}
EUVIMED